Bookman MA - Search Results

1

High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.

Reed E, Janik J, Bookman MA, Rothenberg M, Smith J, Young RC, Ozols RF, VanderMolen L, Kohn E, Jacob JL, et al. Reed E, et al. Among authors: bookman ma. J Clin Oncol. 1993 Nov;11(11):2118-26. doi: 10.1200/JCO.1993.11.11.2118. J Clin Oncol. 1993. PMID: 8229126

2

Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma.

Steis RG, Carrasquillo JA, McCabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW 2nd, Clark JW, Dailey V, Del Vecchio S, et al. Steis RG, et al. Among authors: bookman ma. J Clin Oncol. 1990 Mar;8(3):476-90. doi: 10.1200/JCO.1990.8.3.476. J Clin Oncol. 1990. PMID: 1689772

3

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.

Pai LH, Bookman MA, Ozols RF, Young RC, Smith JW 2nd, Longo DL, Gould B, Frankel A, McClay EF, Howell S, et al. Pai LH, et al. Among authors: bookman ma. J Clin Oncol. 1991 Dec;9(12):2095-103. doi: 10.1200/JCO.1991.9.12.2095. J Clin Oncol. 1991. PMID: 1960550 Clinical Trial.

4

Late complications of Hodgkin's disease management.

Young RC, Bookman MA, Longo DL. Young RC, et al. Among authors: bookman ma. J Natl Cancer Inst Monogr. 1990;(10):55-60. J Natl Cancer Inst Monogr. 1990. PMID: 2189477 Review.

5

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.

Steis RG, Urba WJ, VanderMolen LA, Bookman MA, Smith JW 2nd, Clark JW, Miller RL, Crum ED, Beckner SK, McKnight JE, et al. Steis RG, et al. Among authors: bookman ma. J Clin Oncol. 1990 Oct;8(10):1618-29. doi: 10.1200/JCO.1990.8.10.1618. J Clin Oncol. 1990. PMID: 2213099

6

Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations.

Urba WJ, Clark JW, Steis RG, Bookman MA, Smith JW 2nd, Beckner S, Maluish AE, Rossio JL, Rager H, Ortaldo JR, et al. Urba WJ, et al. Among authors: bookman ma. J Natl Cancer Inst. 1989 Apr 19;81(8):602-11. doi: 10.1093/jnci/81.8.602. J Natl Cancer Inst. 1989. PMID: 2495368

7

Late complications of curative treatment in Hodgkin's disease.

Bookman MA, Longo DL, Young RC. Bookman MA, et al. JAMA. 1988 Aug 5;260(5):680-3. JAMA. 1988. PMID: 3392794 No abstract available.

8

A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.

Broun ER, Iseminger KA, Bookman M. Broun ER, et al. Am J Clin Oncol. 1995 Apr;18(2):164-6. doi: 10.1097/00000421-199504000-00015. Am J Clin Oncol. 1995. PMID: 7900709 Clinical Trial.

9

Future directions for paclitaxel (TAXOL) in the treatment of ovarian cancer.

Bookman MA, Ozols RF. Bookman MA, et al. Semin Oncol Nurs. 1993 Nov;9(4 Suppl 2):21-9. doi: 10.1016/s0749-2081(16)30039-0. Semin Oncol Nurs. 1993. PMID: 7904377 Review.

10

A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.

Look KY, Blessing JA, Adelson MD, Morris M, Bookman MA. Look KY, et al. Among authors: bookman ma. Am J Clin Oncol. 1996 Feb;19(1):7-9. doi: 10.1097/00000421-199602000-00002. Am J Clin Oncol. 1996. PMID: 8554040 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters